Skip to main content

Table 2 Characteristics of infected patients according to the type of malignancy

From: Characteristics and outcomes of cancer patients in European ICUs

  No cancer
(n = 960)
Solid tumours
(n = 168)
Haematological cancer
(n = 49)
Criteria for infection    
   Clinically suspected 750 (78.1%) 136 (81%) 38 (77.6%)
   Microbiologically confirmed 666 (69.4%) 114 (67.9%) 34 (69.5%)
   Clinical signs and micro-organism 383 (39.9%) 71 (42.5%) 14 (28.6%)
Source of infection    
   Respiratory 648 (67.5%) 108 (64.3%) 38 (77.6%)
   Abdominal 200 (20.8%) 56 (33.3%)$ 7 (14.3%)
   Blood stream 196 (20.4%) 26 (15.5%) 16 (32.7)*
   Skin 132 (13.8%) 23 (13.7%) 3 (6.1%)
   Urinary 133 (13.9%) 22 (13.1%) 4 (8.2%)
   Catheter 87 (9.1%) 18 (10.7%) 6 (12.2%)
   Cerebrospinal fluid 15 (1.6%) 0 (0.0%) 0 (0.0%)
   Unknown 53 (5.5%) 7 (4.1%) 3 (6.1%)
Gram-positive bacteria    
   Streptococcus group D 97 (10.1%) 21 (12.5%) 5 (10.2%)
   Streptococcus pneumoniae 42 (4.3%) 3 (1.7%) 1 (2.0%)
   MRSA 131 (13.6%) 28 (16.6%) 5 (10.2%)
   Other cocci 20 (2.1%) 3 (1.8%) 0
Gram-negative bacteria    
   Pseudomonas 132 (13.7%) 21 (12.5%) 10 (20.4%)
   Escherichia coli 114 (11.8%) 34 (20.2%)$ 10 (20.4%)*
   Enterobacter 53 (5.5%) 13 (7.7%) 1 (2.0%)
   Klebsiella 60 (6.2%) 11 (6.5%) 0
   Proteus 39 (4.0%) 9 (5.3%) 1 (2.0%)
   Acinetobacter 37 (3.8%) 3 (1.7%) 2 (4.0%)
   Haemophilus 33 (2.4%) 3 (1.8%) 1 (2.0%)
Fungi    
   Candida albicans 125 (13%) 28 (16.7%) 3 (6.1%)
   Candida non-albicans 37 (3.9%) 9 (5.4%) 3 (6.1%)
   Other fungi 13 (1.3%) 3 (1.7%) 1 (2.0%)
  1. MRSA: methicillin-resistant Staphylococcus aureus. *p < 0.05 versus no-cancer group; $ p < 0.001 versus no-cancer group. Data are presented as number (percentage).